Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
株式のランク #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
株価
$7.15
時価総額
$313.60M
変化(1日)
-2.12%
変化(1年)
-84.14%
DE
取引 Anbio Biotechnology Class A Ordinary Shares (NNNN)

カテゴリー

Anbio Biotechnology Class A Ordinary Shares(NNNN)の配当利回りの履歴
Anbio Biotechnology Class A Ordinary Shares(銘柄コード: NNNN)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Anbio Biotechnology Class A Ordinary Shares(NNNN)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)